NASDAQ: TDAC
Translational Development Acquisition Corp Stock

$10.35+0.00 (+0%)
Updated Jul 30, 2025
TDAC Price
$10.35
Fair Value Price
N/A
Market Cap
$226.74M
52 Week Low
$10.00
52 Week High
$10.35
P/E
N/A
P/B
-38.14x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.07
Operating Cash Flow
N/A
Beta
-0.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

TDAC Overview

Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine TDAC's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Shell Company

Industry Rating
F
TDAC
Ranked
Unranked of 37

Top Ranked Stocks in Industry

View Top Shell Company Stocks

Be the first to know about important TDAC news, forecast changes, insider trades & much more!

TDAC News

Overview

Due Diligence Score

Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TDAC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TDAC's short-term assets ($415.42k) exceed its short-term liabilities ($322.90k)
Short-term Liabilities Financials
TDAC's long-term liabilities ($6.04M) exceed its short-term assets ($415.42k)
Long-term Liabilities Financials
TDAC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
There are 30 more TDAC due diligence checks available for Premium users.

Valuation

TDAC price to earnings (PE)

For valuing profitable companies with steady earnings

Company
0x
Industry
12.88x
Market
32.18x

TDAC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-38.14x
Industry
-68.06x

TDAC's financial health

Profit margin

Revenue
$0.0
Net Income
$1.5M
Profit Margin
0%

Assets to liabilities

Assets
$176.6M
Liabilities
$6.4M
Debt to equity
-1.07
TDAC's short-term assets ($415.42k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TDAC's long-term liabilities ($6.04M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TDAC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TDAC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$231.6k
Investing
$0.0
Financing
$0.0

TDAC vs Shell Company Stocks

TickerZen RatingMarket Cap1d %P/EP/B
TDAC$226.74M0.00%N/A-38.14x
MACI$228.11M+0.38%31.97x-40.14x
SVCC$221.90M0.00%N/A-47.30x
COPLC$232.98M-0.06%N/A-1,966.28x
UMACD$233.40M+1.18%-2.42x14.68x

Translational Development Acquisition Stock FAQ

What is Translational Development Acquisition's quote symbol?

(NASDAQ: TDAC) Translational Development Acquisition trades on the NASDAQ under the ticker symbol TDAC. Translational Development Acquisition stock quotes can also be displayed as NASDAQ: TDAC.

If you're new to stock investing, here's how to buy Translational Development Acquisition stock.

What is the 52 week high and low for Translational Development Acquisition (NASDAQ: TDAC)?

(NASDAQ: TDAC) Translational Development Acquisition's 52-week high was $10.35, and its 52-week low was $10.00. It is currently at its 52-week high and 3.5% from its 52-week low.

How much is Translational Development Acquisition's stock price per share?

(NASDAQ: TDAC) Translational Development Acquisition stock price per share is $10.35 today (as of Jul 30, 2025).

What is Translational Development Acquisition's Market Cap?

(NASDAQ: TDAC) Translational Development Acquisition's market cap is $226.74M, as of Jul 31, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Translational Development Acquisition's market cap is calculated by multiplying TDAC's current stock price of $10.35 by TDAC's total outstanding shares of 21,907,500.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.